Why Elevance Health Inc. (ELV) stock moved
Why Elevance Health Inc. (ELV) fell 2.8% on November 17, 2026
Elevance Health Inc. (ELV) fell 2.8% on November 17, 2026, closing at $433.93 versus $446.28 the prior session (close-to-close, from daily closes). Elevance Health survey reveals 82% of Americans want simplified, personalized healthcare with AI playing a role. Source: Business Wire.
Elevance Health survey reveals 82% of Americans want simplified, personalized healthcare with AI playing a role.
What to watch next: Data supports market demand for AI-driven solutions, potentially validating ELV's digital health strategy and growth opportunities.
Earlier sessions that moved ELV
- +3.9%Driven by positive investor sentiment following management's 2027 growth guidance of at least 12% adjusted EPS growth (highlighted at recent investor conferences including UBS) and strengthening expectations for Medicaid margin recovery in 2027 as state regulators adjust reimbursement rates upward.
- +4.9%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
- +2.6%Elevance Health filed an earnings report and material event (8-K) today, driving a +2.73% intraday gain to $446.00.
- +2.9%We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found.
- +4.9%Elevance Health rose 4.9% on September 10, 2026, driven by management's reaffirmation of full-year 2026 earnings per share and cost guidance, which reassured investors about operational stability amid managed-care sector pressures. Read the September 10, 2026 analysis →
- +2.7%Following Q2 earnings that beat revenue estimates at $49.83 billion and prompted raised full-year guidance, per Yahoo Finance and WSJ sources.
Elevance Health Inc. (ELV) shares fell 2.8% to $433.93 at the November 17, 2026 close, a moderate decline from the prior close of $446.28. That close is the latest confirmed price for ELV; a live quote was not available. BestStocks flagged the session as a major change for ELV. Below, we break down what changed for ELV, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
ELV fell 2.8% to $433.93
Elevance Health fell 5.26% to $411.09, driven by sector-wide managed-care and Medicaid margin concerns alongside medical cost trend anxiety (elevated ACA and Medicaid claim utilization), per web research. Volume of 551,891 shares in the first 120 minutes represents 1.29x the historical average for this time of day, indicating normal participation for the intraday period. ELV earnings scheduled for January 27, 2027 (consensus EPS estimate $2.08); also monitor Medicaid utilization trends and updates on cost management initiatives that could signal progress toward the projected 2027 margin recovery.
What it means for Elevance Health Inc. investors
For Elevance Health Inc. investors, the recent signals add up to a bearish shift. On the constructive side: Positive price momentum; ELV rallied +3.09% to $423.15, eclipsing its 52-week high of $422.65 as the stock extended gains driven by sector strength and positive earnings guidance. Weighing against that: Negative session, down 2.8%; Elevance Health reported Q2 2026 earnings before market open showing a sharp 30% year-over-year earnings decline to ~$6.18 per share, driven by surging medical costs and worsening medical loss ratios (Established source, uk.investing.com). BestStocks rates the overall signal quality weak (39/100). With earnings roughly 70 days out, the next report is the most likely near-term test of the move.
ELV price reaction
ELV last traded at $433.93, down $12.35 (-2.77%) from the previous close of $446.28.
The bull and bear case for ELV stock
Weighing the constructive signals against the risks, here is how the bull and bear case for Elevance Health Inc. (ELV) lines up on the latest data.
The bullish case
- Positive price momentum.
- ELV rallied +3.09% to $423.15, eclipsing its 52-week high of $422.65 as the stock extended gains driven by sector strength and positive earnings guidance.
The bearish case
- Negative session, down 2.8%.
- Elevance Health reported Q2 2026 earnings before market open showing a sharp 30% year-over-year earnings decline to ~$6.18 per share, driven by surging medical costs and worsening medical loss ratios (Established source, uk.investing.com).
Weighing both sides, BestStocks' composite read of recent signals is bearish, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Previous notable changes for ELV
Frequently asked questions about ELV
Why did Elevance Health Inc. (ELV) stock move?
Elevance Health Inc. (ELV) fell 2.8% on November 17, 2026, closing at $433.93 versus $446.28 the prior session (close-to-close, from daily closes). Elevance Health survey reveals 82% of Americans want simplified, personalized healthcare with AI playing a role. Source: Business Wire.
How much did ELV stock fall?
ELV lost 2.77% ($12.35) versus the prior close of $446.28, last trading at $433.93.
When is Elevance Health Inc.'s next earnings date?
ELV's next earnings report is scheduled for 2027-01-27 — about 70 days away.
How BestStocks tracks ELV
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared ELV-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for ELV, cross-checked against the data sources listed below. A live intraday quote was not available, so price and volume figures are the confirmed end-of-day close from November 17, 2026 — not the current price — and the percentage move is that session's. They refresh once live quotes resume. For companies with multiple share classes, market-cap figures can differ by data source. This is an educational summary of what changed and why — not personalized investment advice.
